共 22 条
[1]
Sakuramoto S(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med. 357 1810-1820
[2]
Sasako M(2011)Macroscopic serosal classification predicts peritoneal recurrence for patients with gastric cancer underwent potentially curative surgery Ann Surg Oncol. 18 1068-1080
[3]
Yamaguchi T(2010)Survival prediction of gastric cancer by a seven-microRNA signature Gut. 59 579-585
[4]
Sun Z(2010)Bionetworks-based personalized medicine versus comparative-effectiveness research or harmonization of both in cancer management? Expert Rev Mol Diagn 10 247-250
[5]
Xu YY(2011)Trastuzumab and beyond: sequencing cancer genomes and predicting molecular networks Pharmacogenomics J 11 81-92
[6]
Wang ZN(2010)Next-generation sequencing and epigenome technologies: potential medical applications Expert Rev Med Devices 7 723-726
[7]
Li X(2010)Complete genome sequencing and network modeling to overcome trastuzumab resistance Pharmacogenomics 11 1039-1043
[8]
Zhang Y(2010)Next-generation, genome sequencing-based biomarkers: concerns and challenges for medical practice Biomark Med 4 583-586
[9]
Zhang Y(2010)Individual genomes and personalized medicine: life diversity and complexity Per Med 7 347-350
[10]
Ding J(2010)Genotype-phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment Expert Rev Mol Diagn 10 541-545